Back to Search
DR. GREGORY GEORGE WESTIN MD
MD
Vascular Surgery Physician
NPI: 1659676146IndividualAccepts Medicare
Specialties, Licenses & Credentials
Vascular Surgery PhysicianPrimary
Surgery — Vascular Surgery
Code: 2086S0129X
285937(NY)01082541A(IN)
Education
UNIVERSITY OF CALIFORNIA, DAVIS SCHOOL OF MEDICINE
Class of 2014
Research & Publications (20)
Synthesis, characterization, and properties of three europium 2-propoxides: [Eu(4)(OPr(i))(10)(HOPr(i))(3)]*2HOPr(i), Eu(5)O(OPr(i))(13), and EuAl(3)(OPr(i))(12).
PMID 12055004·Inorg Chem·2002
8-other
Two polypyrimidine tracts in the nitric oxide synthase 2 gene: similar regulatory sequences with different properties.
PMID 19669598·Mol Biol Rep·2010
8-other
Stathmin as a marker for malignancy in pheochromocytomas.
PMID 19449284·Exp Clin Endocrinol Diabetes·2010
4-observational
The internally truncated LRP5 receptor presents a therapeutic target in breast cancer.
PMID 19158955·PLoS One·2009
7-preclinical
Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen.
PMID 18322283·N Engl J Med·2008
8-other
Type I membrane klotho expression is decreased and inversely correlated to serum calcium in primary hyperparathyroidism.
PMID 18682507·J Clin Endocrinol Metab·2008
7-preclinical
Evaluation of CDKN2C/p18, CDKN1B/p27 and CDKN2B/p15 mRNA expression, and CpG methylation status in sporadic and MEN1-associated pancreatic endocrine tumours.
PMID 17803708·Clin Endocrinol (Oxf)·2008
8-other
Stabilizing mutation of CTNNB1/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients.
PMID 18541010·Mol Cancer·2008
8-other
An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT/beta-catenin signaling.
PMID 18044981·PLoS Med·2007
7-preclinical
Potentiating effects of nonactive/active vitamin D analogues and ketoconazole in parathyroid cells.
PMID 17302875·Clin Endocrinol (Oxf)·2007
7-preclinical
Accumulation of nonphosphorylated beta-catenin and c-myc in primary and uremic secondary hyperparathyroid tumors.
PMID 17047023·J Clin Endocrinol Metab·2007
8-other
Cyclin-dependent kinase 4 (CDK4) expression in pancreatic endocrine tumors.
PMID 17664862·Neuroendocrinology·2007
8-other
Mutational analysis of p27 (CDKN1B) and p18 (CDKN2C) in sporadic pancreatic endocrine tumors argues against tumor-suppressor function.
PMID 17710155·Neoplasia·2007
8-other
Activated beta-catenin in the novel human parathyroid tumor cell line sHPT-1.
PMID 17126301·Biochem Biophys Res Commun·2007
8-other
Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells.
PMID 17911404·J Endocrinol·2007
7-preclinical
Mutational analyses of WNT7A and HDAC11 as candidate tumour suppressor genes in sporadic malignant pancreatic endocrine tumours.
PMID 17201809·Clin Endocrinol (Oxf)·2007
8-other
Adsorption and solar light decomposition of acetone on anatase TiO2 and niobium doped TiO2 thin films.
PMID 16471666·J Phys Chem B·2006
8-other
Detailed assessment of chromosome 22 aberrations in sporadic pheochromocytoma using array-CGH.
PMID 16161042·Int J Cancer·2006
8-other
25-hydroxyvitamin D3 1alpha-hydroxylase and vitamin D receptor expression in papillary thyroid carcinoma.
PMID 16314444·J Histochem Cytochem·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 2651 E DISCOVERY PKWY
BLOOMINGTON, IN 47408 - Phone
- (812) 355-6900
Quick Facts
- NPI
- 1659676146
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 12
- Publications
- 20
Are you this provider?
Claim Your Profile